Delivery Order SPE2DR25D1052-SPE2DR26F6DC8
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 26, 2026, for Isotretinoin 30 mg capsules with a ceiling value of $2,969.01. This non-set-aside, firm fixed-price delivery order is scheduled for completion by January 27, 2026, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,074.58 on November 5, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 6, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,269.27 for 30 mg Isotretinoin capsules (30-count supply) with an ultimate completion date of November 17, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,578.20 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (10-count units) on November 18, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $6,962.71 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 9, 2026, with an ultimate completion date of January 12, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,377.62 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 28, 2026, with an ultimate completion date of January 29, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $11,763.80 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules in quantities of 30 units. This contract is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location and is a major pharmaceutical distributor specializing in medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,326.47 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on February 2, 2026, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of February 3, 2026. The work will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,619.93 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent...
- SPE2DR25D1052Indefinite Delivery Contract
- SPE2DR25D1052-SPE2DR26F6DC8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,542.78 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) on February 3, 2026, with completion scheduled for February 4, 2026. This firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the awardee's location in Conshohocken, Pennsylvania. The contract represents a task order execution under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (formerly doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical federal medical procurement vendor. The parent company, Cencora, Inc., holds the primary IDC with DLA Troop Support Medical and competes on a full and open basis for federal contracts without set-aside restrictions. Through these contract vehicles, the company supplies an extensive range of pharmaceutical products across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions, positioning it as a key strategic partner in the Defense Logistics Agency's global pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 2/2/26 |